ロード中...
Are aromatase inhibitors associated with higher myocardial infarction risk in breast cancer patients? A Medicare population‐based study
BACKGROUND: Theoretically, the estrogen deprivation induced by aromatase inhibitors (AIs) might cause ischemic heart disease, but empiric studies have shown mixed results. We aimed to compare AIs and tamoxifen with regard to cardiovascular events among older breast cancer patients outside of clinica...
保存先:
| 出版年: | Clin Cardiol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wiley Periodicals, Inc.
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6344290/ https://ncbi.nlm.nih.gov/pubmed/30443921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23114 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|